Villaganas, Jesus A.
HRN: 05-40-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/23/2022
12/30/2022
IV
1.5 Grams
Q6H
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes